Epi-Ivermectin B1a

• Description:

  Epi-Ivermectin B1a is a key related substance of Ivermectin (HY-15310), primarily existing as a process-related impurity or potential degradation product in ivermectin-based antiparasitic formulations. epi-Ivermectin B1a can be used for the study of internal/external parasites in cattle[1].

• Product Name Alternative:

  22,23-Dihydro avermectin B1a; epi-Dihydro avermectin B1a

• UNSPSC:

  12352005

• Target:

  Parasite

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Smiles:

  C/C ([C@H] ([C@H] (/C=C/C=C1CO[C@] ([H]) ([C@@H] (C (C) =C[C@@]2 (C3=O) [H]) O) [C@@]\12O) C) O[C@]4 (C[C@@H] ([C@H] ([C@@H] (O4) C) O[C@@]5 (O[C@H] ([C@@H] ([C@H] (C5) OC) O) C) [H]) OC) [H]) =C\C[C@@]6 (C[C@@] ([H]) (C[C@@]7 (O6) CC[C@@H] ([C@] ([H]) (O7) [C@@H] (C) CC) C) O3) [H]

• Molecular Formula:

  C48H74O14

• Molecular Weight:

  875.09

• References & Citations:

  [1]Padivitage N, et al. Simultaneous determination of ivermectin, clorsulon and their related substances in an injectable finished product by a stability-indicating RP-HPLC method. J Pharm Biomed Anal. 2022 Feb 20;210:114580.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Natural Products

• Clinical Information:

  No Development Reported

• CAS Number:

  2962875-16-5